The global transcatheter aortic valve replacement market is anticipated to grow at a considerable CAGR of around 11.4% during the forecast period (2021-2027). Transcatheter Aortic Valve Replacement (TAVR) is a surgery that is needed to perform which will improve the quality of life of individuals suffering from valvular diseases. these surgeries have a high success rate that increases the demand for these surgeries. This treatment success rate increases the awareness among people across the globe. Thus, it will help in the growth of the market rapidly. The TAVR has been approved by the regulatory bodies and is available for patients receiving Medicaid and Medicare facilities.
Browse the full report description of "Global Transcatheter Aortic Valve Replacement Market Size, Share & Trends Analysis By Approach (Transfemoral Approach, Transapical Approach, and Transaortic Approach), By Application (Aortic Valvular Heart Disease, Mitral Valvular Heart Disease, and Pulmonary Valvular Heart Disease), By End-User (Hospitals, Cardiac Centres, and Ambulatory Surgical Centres) Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/transcatheter-aortic-valve-replacement-market
The major factor that drives the growth of the market includes increasing prevalence of aortic stenosis (AS) and aortic regurgitation (AR), rising incidence of chronic diseases, reimbursement policies further increase the growth of the global TAVR market, owning these factors the demand of the healthcare expenditure is increasing. The key market players adopting different market strategies such as the US FDA, for instance, In January 2020, Jenavalve Technology, Inc. received a “Breakthrough Device” designation from the US Food and Drug Administration (FDA) for its Pericardial TAVR System. It is one of the first transcatheter devices to achieve advanced device designation that arranges premarket approval expansion path for plain aortic regurgitation Indication. This title is for severe aortic regurgitation (AR). the FDA provided JenaValve with precedence appraisal and collaborating communication about clinical trial protocols, and device development, through commercialization conclusions. The device is used for the treatment of patients having life-threatening or irreversibly debilitating diseases or conditions
Market Coverage
o By Approach
o By Application
o ByEnd-User
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Transcatheter Aortic Valve Replacement Market
By Approach
By Application
By End-User Industry
Global Transcatheter Aortic Valve Replacement Market by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/transcatheter-aortic-valve-replacement-market